Search

Author/Creator Delemarre, Eveline

1. Biomarkers in tear fluid of dupilumab‐treated moderate‐to‐severe atopic dermatitis patients. Issue 2 (22nd December 2022)

Authors:
Achten, Roselie; Thijs, Judith; van Luijk, Chantal; Knol, Edward; Delemarre, Eveline; de Graaf, Marlies; Bakker, Daphne; de Boer, Joke; van Wijk, Femke; de Bruin‐Weller, Marjolein
Journal:
Clinical & experimental allergy
Issue:
Volume 53:Issue 2(2023)
Page Start:
239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease. Issue 1 (16th January 2023)

Authors:
Achten, Roselie; Thijs, Judith; van der Wal, Marlot; van Luijk, Chantal; van Luin, Matthijs; el Amrani, Mohsin; Knol, Edward; Delemarre, Eveline; Jager, Constance den Hartog; de Graaf, Marlies; Bakker, Daphne; de Boer, Joke; van Wijk, Femke; de Bruin‐Weller, Marjolein
Journal:
Clinical and translational allergy
Issue:
Volume 13:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TLR9 agonist CpG enhances protective nasal HSP60 peptide vaccine efficacy in experimental autoimmune arthritis. Issue 10 (5th May 2012)

Authors:
Zonneveld-Huijssoon, Evelien; van Wijk, Femke; Roord, Sarah; Delemarre, Eveline; Meerding, Jenny; de Jager, Wilco; Klein, Mark; Raz, Eyal; Albani, Salvatore; Kuis, Wietse; Boes, Marianne; Prakken, Berent J
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71:Issue 10(2012)
Page Start:
1706
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗